Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Year-end report 1 April 2019 – 31 March 2020

Fourth quarter (1 January - 31 March 2020) · Net sales increased by 6 percent and amounted to SEK 3,038 million (2,864). · Operating profit before amortisation of intangible non-current assets (EBITA) increased by 32 percent and amounted to SEK 407 million (309) corresponding to an EBITA margin of 13.4 percent (10.8). · Operating profit increased by 35 percent and amounted to SEK 352 million (260) corresponding to an operating margin of 11.6 percent (9.1). · Profit after tax increased by 47 percent and amounted to SEK 265 million (180) and earnings per share before dilution

STENOCARE – First day of trading on NASDAQ FIRST NORTH GROWTH MARKET DENMARK will be 18 May 2020

STENOCARE A/S (“STENOCARE”) has been approved for listing on Nasdaq First North Growth Market Denmark. The company hereby announce that the first day of trading will be on 18 May 2020 under the symbol “STENO”. The company will be delisted from Spotlight Stock Market and the last day of trading will be on 15 May 2020.Certified Adviser at the time of listing STENOCARE’s Certified Adviser will be Keswick Global AG, Reg. FN 332389 h, Hoffingergasse 16/1/6, 1120 Vienna, Austria, telephone number +43 (1) 533 88 90 0. Danish Law STENOCARE is a Danish company operating under Danish law,

Azelio interim report: The verification project started

The verification of Azelio’s storage technology in partnership with leading certification company DNV-GL has begun. An inauguration of Azelio’s energy storage took place at one of the world’s largest solar parks, Noor in Morocco. It was attended by government representatives, the World Bank and IFC, among others. In view of the current travel restrictions due to Covid-19 the verification will initially focus on the installation in Åmål, Sweden. Preparations for starting the verification of a further four energy storage units in Abu Dhabi, in collaboration with the company’s partners Masdar

Invitation to presentation of Embracer Group's Q4 and full-year report

Embracer Group hereby invites you to a presentation in connection with the publishing of the full-year report for fiscal year 2019/2020 and the interim report for the fourth quarter, the period January-March 2020. The report will be published at 06.00 (CET) on May 20[th].The presentation will be held in English by CEO Lars Wingefors and CFO Johan Ekström, and afterward questions are invited. Covid-19The Embracer Group safeguards stakeholders' health and strives to help limit the spread of the coronavirus, as well as comply with applicable restrictions and regulatory recommendations. As

Report for the first quarter 2020

Financial and operating highlights 1Q20 (1Q19 in brackets): · Operating revenues were NOK 1 967 million (NOK 1 687 million) · EBITDA was NOK 250 million (NOK 251 million) · Impairment in the quarter NOK 93 million (NOK 0 million) · EBIT was NOK -101 million (NOK 22 million) · Net result after tax was NOK 118 million (NOK -200 million) Segment highlights 1Q20 (1Q19 in brackets): Renewable energy · EBITDA NOK 419 mill. (NOK 384 mill.) · Total generation up 24% · Year on year decreasing electricity prices in all markets · Sale of 51% stake in GWP France,

Interim report for Q1 2020

The development of the Covid-19 pandemic has painfully highlighted the urgent need for infection prevention. This has led to an increased interest in Bactiguard and generated strong sales from mid-March. Total revenues increased by more than 40 percent in the quarter and EBITDA doubled, generating an EBITDA margin of 30 percent and a positive net result.First quarter (January-March 2020) · Revenues amounted to SEK 48,1 (33,9) million and increased by 42% (adjusted for currency 36%). · EBITDA amounted to SEK 14,4 (7,2) million with an EBITDA-margin of 30% (21%). · Operating profit

Interim Financial Report Q1-2020: First patient enrolled in Phase 3 study SPARKLE

Ascelia Pharma AB (publ) (ticker: ACE) today published its interim financial report for Q1-2020 (January – March 2020), which is now available on the company’s website: https://www.ascelia.com/tag/reports-presentations/SIGNIFICANT EVENTS IN Q1-2020 · First patient enrolled in Mangoral’s Phase 3 study SPARKLE · Additional clinical sites opened for patient enrolment · Ascelia Pharma wins the award as the best Life Science company in Malmö, Sweden SIGNIFICANT EVENTS AFTER THE PERIOD · Patent for Oncoral approved in Japan · First participant enrolled in the clinical

OssDsign AB (publ) publishes Q1 2020 interim report

The positive trend from the end of 2019 continues as OssDsign kicks off 2020 with continued  consecutive sales growth of 52% in Q1 vs Q4 2019.The first quarter in figures · Net sales amounted to TSEK 7 726 (3,514). · Loss after taxes amounted to TSEK 18 312 (17 340). · Loss per share was SEK 1,0 (1,5). · Cash flow from current operations was TSEK -21 898  (-22 547).  Important events during the first quarter ·The company has signed a new lease for the head office and  state of the art manufacturing facility in Uppsala, Sweden. · Completed transfer of the

Financial Report 2019/20 1 April 2019-31 March 2020

FINANCIAL YEAR 2019/20 (1 April 2019-31 March 2020) · Revenue increased by 2 percent to MSEK 6,135 (6,024). · EBITA (excluding items affecting comparability of MSEK –14 pertaining to costs arising from the acquisition of Swedol) rose by 6 percent to MSEK 338 (318), corresponding to an EBITA margin of 5.5 percent (5.3). · Adjusted operating profit (excluding items affecting comparability) increased to MSEK 317 (302), corresponding to an adjusted operating margin of 5.2 percent (5.0). Operating profit amounted to MSEK 303 (302) and the operating margin to 4.9 percent (5.0). ·

Hansa Biopharma to participate in five upcoming investor conferences during May and June

Hansa Biopharma has been invited to participate in five healthcare conferences during May and June including UBS Global Healthcare Conference, RBC Global Healthcare Conference, ABG Life Science Summit, Redeye Orphan Drug Event and Citi’s European Healthcare Conference.Lund, Sweden May 13, 2020. Hansa Biopharma, the leader in immunomodulatory enzyme technology for rare IgG mediated diseases, today announced that the Company’s management team will participate in the following upcoming investor conferences: · UBS Global Healthcare Conference on Monday, May 18, 2020, with a presentation at

MAG moves publication date of the Q3 interim report

Stockholm, Sweden - 13 May - The Board of Directors of MAG Interactive AB (publ) has decided to move the publication of the interim report for the period September 1, 2019 - May 31, 2020 from July 1, 2020 to June 30, 2020. The decision was made to enable those in leadership positions within the company to exercise warrants within the framework of the warrants program 2017/20:1 during a slightly extended portion of the exercise period.

Gas filling station network expands to Järvenpää in Finland

Energy company Gasum is to build the first gas filling station in Järvenpää, in the Boogie business district. The new gas filling station will enjoy an excellent location at a traffic hub and will strengthen Gasum’s network of stations, especially in Central Uusimaa. The City of Järvenpää is striving for carbon neutrality by 2035 as part of the Resource Wisdom Järvenpää project, and the new filling station will contribute to promoting this objective. The gas filling station is expected to open by the end of 2020.Gasum is further strengthening its gas filling station network in Southern

Bactiguard appoints Gabriella Björknert Caracciolo as new CFO

Bactiguard Holding AB (publ) has appointed Gabriella Björknert Caracciolo, currently Head of Strategy, Development and Governance within Transaction Banking, Nordea as new CFO and Executive Vice President. She succeeds Cecilia Edström, who in February was appointed CEO of the company. Gabriella Björknert Caracciolo assumes her new position in August 2020.“Gabriella Caracciolo is an experienced and development oriented leader with a strong business focus and broad experience. Her financial skills are solid, and she has extensive experience in driving business transformations. These are

Notice to the Annual General Meeting of Basware Corporation

Basware Corporation, stock exchange release, May 13, 2020 at 8.30 am EESTNotice is given to the shareholders of Basware Corporation to the Annual General Meeting to be held on 4 June, 2020 at 1:00 PM at the company’s headquarters, at the address Linnoitustie 2, Cello-rakennus, 02601 Espoo, Finland. Basware takes the coronavirus situation very seriously and aims to ensure the best interests of the company and its shareholders by holding the Annual General Meeting on 4 June, 2020. The company will impose several precautionary measures to be able to hold the meeting and to ensure the safety

Ferronordic AB (publ) Interim Report January - March 2020

Growth in Russia/CIS. Start of operations in GermanyFIRST QUARTER 2020 · Revenue increased by 55% to SEK 1,118m (SEK 723m) · Operating profit decreased by 9% to SEK 51m (SEK 56m) · Operating margin decreased to 4.6% (7.7%) · The result for the period decreased by 56% to SEK 20m (SEK 46m) · Earnings per ordinary share amounted to SEK 1.39 (SEK 3.19) · Cash flows from operating activities amounted to SEK 101m (SEK -116m) SEK M Q1 Q1 % 2020* 2019Revenue 1 118 723 55%Operating profit

Sprint Bioscience announces the identity of the target protein in the wholly-owned project VADA

Sprint Bioscience today announces that after a series of preclinical research advances in the VADA project, it has been decided to publish the project's target protein. The goal is to develop drug substances that inhibit the protein vaccinia-related kinase 1 (VRK1) in order to enhance the effects of immuno-oncology therapy, radiation therapy and chemotherapy. The company believes that this approach paves the way for a unique position in the market for innovative drug projects and will now initiate contacts with potential partners.The new target protein VRK1 acts by regulating the activity

Indosat Ooredoo selects Ericsson Operations Engine

· Deal will provide nationwide AI-driven managed services and network automation for Indosat Ooredoo in Indonesia · Indosat Ooredoo to launch Ericsson Operations Engine in July 2020   · Solution will deliver operational, energy, cost efficiency and strengthened network capabilities to Indosat OoredooEricsson (NASDAQ: ERIC) has been selected by Indonesian communications service provider Indosat Ooredoo (IDX:ISAT) to provide AI-powered data driven and customer-centric managed network operations through the Ericsson Operations Engine. The five-year deal will see Indosat Ooredoo

Ambea’s interim report January-March 2020

CEO comment: The fight against COVID-19 marked the latter part of the first quarter and the whole organisation has made a tremendous contribution to contain the spread. A challenging time, but Ambea was able to capitalise on the overall competence of our Scandinavian organisation. In our activities related to COVID-19, we have strived to stay one step ahead and used preventive measures to keep the virus out of our facilities and to limit its spread. The early introduction of visiting restrictions, support in routines and intensive work to ensure the supply of PPE were all important

BERGENBIO ASA: Invitation to first quarter 2020 results webcast presentation

Bergen, Norway, 13 May 2020 – BerGenBio ASA (OSE:BGBIO), will announce its results for the first quarter 2020 on Tuesday 19 May 2020. A webcast presentation by BerGenBio’s senior management team will take place at 10 am CET. The presentation will webcast live and the link will be available at www.bergenbio.com in the section Investors/Financial Reports. A recording will be available shortly after the webcast has finished. The results report and presentation will be available at www.bergenbio.com in the section: Investors/Financial Reports from 7:00 am CET the same day. -Ends-

Swedbank acts as structuring advisor to K2A in the development of the first Green Equity Framework

Today K2A announced the launch of its Green Equity Framework. Swedbank has acted as Sole structuring advisor, and a second opinion has been made by the independent research center, CICERO Shades of Green (“CICERO”). This will allow K2A to be the first company in the world to shade its equity, both current and future, as green.The equity side of green financing has so far not received much attention comparing to green debt. However, as the market for sustainable bonds has increased in recent years the behaviour and investment strategies of dedicated green investors have changed. The focus

Independent sleep tracking and silent wake up prime features of brand new Sleep Cycle Apple Watch App

GOTHENBURG, Sweden—May 13, 2020—Sleep Cycle alarm clock, the best selling alarm clock and top rated sleep tracker application, now releases its new Apple Watch app, featuring sleep tracking in the watch, with no need to have the iPhone by your bed.“In line with improved battery life and new features released by Apple, we see a growing in- terest and need from users to start wearing the Apple Watch to bed.” said Carl Johan He- deroth, CEO of Sleep Cycle. “For our relaunch of the Sleep Cycle Apple Watch app we saw a great opportunity in developing a solution that would allow the watch app to

SEMAFO: Cash Flow from Operating Activities before Changes in non-Cash Working Capital of $60 Million and Transaction Update

This is information that SEMAFO Inc. is obliged to make public pursuant to the EU Market Abuse Regulation.The information was submitted for publication, through the agency of the contact person set out below,at 9 p.m. Eastern time on May 12, 2020.Montreal, Quebec, May 12, 2020 – SEMAFO Inc. (TSX, OMX: SMF) is pleased to announce results of operations for the three-month period ended March 31, 2020. All amounts are in US dollars unless otherwise stated. Highlights The following 2020 highlights include a 4-week suspension of operations at the Boungou Mine. · Signing of

There are no items matching the current filter
There are no more items matching the current filter
Back to top